MGI Tech Singapore Pte, Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore (“NCCS”) to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI’s core DNBSEQ™ technology.
From Comfort to Cure’: Answering the Call of ASCO 2024
Dr. Robert Den, Chief Medical Officer at Alpha Tau Medical The landscape of cancer treatment has continued to evolve, and the annual ASCO Meetings often
August 16, 2024